{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:58:39Z","timestamp":1780095519978,"version":"3.54.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda-Fondo Sectorial Salud","award":["2012-01181492"],"award-info":[{"award-number":["2012-01181492"]}]},{"name":"Fondo de Investigaci\u00f3n en Salud-IMSS","award":["FIS-IMSS-G11-935"],"award-info":[{"award-number":["FIS-IMSS-G11-935"]}]},{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda-Fondo de Cooperaci\u00f3n Internacional Mexico-Alemania","award":["207978"],"award-info":[{"award-number":["207978"]}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01DN15002"],"award-info":[{"award-number":["01DN15002"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00408-019-00244-1","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T14:06:31Z","timestamp":1562076391000},"page":"641-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma"],"prefix":"10.1007","volume":"197","author":[{"given":"Carmina","family":"Jim\u00e9nez-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaantje","family":"Casjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuauht\u00e9moc Arturo","family":"Ju\u00e1rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Raiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz M.","family":"Del Razo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"Calder\u00f3n-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Rihs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor Concepci\u00f3n","family":"Acosta-Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Gilbert","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cabello-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Ochoa-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Burek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Torre-Bouscoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Rogelio","family":"P\u00e9rez-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Marco","family":"Garc\u00eda-Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3773-5946","authenticated-orcid":false,"given":"Georg","family":"Johnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-4105","authenticated-orcid":false,"given":"Guadalupe","family":"Aguilar-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"244_CR1","doi-asserted-by":"crossref","unstructured":"IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: asbestos (1977). IARC Monogr Eval Carcinog Risk Chem Man 14:1\u2013106","DOI":"10.1016\/S0015-6264(76)80033-8"},{"key":"244_CR2","first-page":"770","volume":"54","author":"R Gopar-Nieto","year":"2016","unstructured":"Gopar-Nieto R, Cabello-Lopez A, Juarez-Perez CA, Haro-Garcia LC, Jimenez-Ramirez C, Aguilar-Madrid G (2016) Update on epidemiology, pathophysiology, diagnosis and treatment of malignant pleural mesothelioma. Rev Med Inst Mex Seguro Soc 54:770\u2013776","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"244_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1179\/oeh.2003.9.3.272","volume":"9","author":"G Aguilar-Madrid","year":"2003","unstructured":"Aguilar-Madrid G, Juarez-Perez CA, Markowitz S, Hernandez-Avila M, Sanchez Roman FR, Vazquez Grameix JH (2003) Globalization and the transfer of hazardous industry: asbestos in Mexico, 1979\u20132000. Int J Occup Environ Health 9:272\u2013279. https:\/\/doi.org\/10.1179\/oeh.2003.9.3.272","journal-title":"Int J Occup Environ Health"},{"key":"244_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ajim.20780","volume":"53","author":"G Aguilar-Madrid","year":"2010","unstructured":"Aguilar-Madrid G, Robles-Perez E, Juarez-Perez CA, Alvarado-Cabrero I, Rico-Mendez FG, Javier KG (2010) Case-control study of pleural mesothelioma in workers with social security in Mexico. Am J Ind Med 53:241\u2013251. https:\/\/doi.org\/10.1002\/ajim.20780","journal-title":"Am J Ind Med"},{"key":"244_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ordonez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Salle F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 142:89\u2013108. https:\/\/doi.org\/10.5858\/arpa.2017-0124-RA","journal-title":"Arch Pathol Lab Med"},{"key":"244_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/107327480601300402","volume":"13","author":"R Ismail-Khan","year":"2006","unstructured":"Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR (2006) Malignant pleural mesothelioma: a comprehensive review. Cancer Control 13:255\u2013263. https:\/\/doi.org\/10.1177\/107327480601300402","journal-title":"Cancer Control"},{"key":"244_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.disamonth.2010.12.004","volume":"57","author":"G Fuhrer","year":"2011","unstructured":"Fuhrer G, Lazarus AA (2011) Mesothelioma. Dis Mon 57:40\u201354. https:\/\/doi.org\/10.1016\/j.disamonth.2010.12.004","journal-title":"Dis Mon"},{"key":"244_CR8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12885-017-3375-5","volume":"17","author":"G Johnen","year":"2017","unstructured":"Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, Taeger D, Lehnert M, Kollmeier J, Bauer T, Musk AW, Robinson BWS, Bruning T, Creaney J (2017) Calretinin as a blood-based biomarker for mesothelioma. BMC Cancer 17:386. https:\/\/doi.org\/10.1186\/s12885-017-3375-5","journal-title":"BMC Cancer"},{"key":"244_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/jco.2011.39.6671","volume":"30","author":"K Hollevoet","year":"2012","unstructured":"Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A, Cristaudo A, Pass HI, Nackaerts K, Rodriguez Portal JA, Schneider J, Muley T, Di Serio F, Baas P, Tomasetti M, Rai AJ, van Meerbeeck JP (2012) Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 30:1541\u20131549. https:\/\/doi.org\/10.1200\/jco.2011.39.6671","journal-title":"J Clin Oncol"},{"key":"244_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1155\/2013\/874212","volume":"35","author":"J Creaney","year":"2013","unstructured":"Creaney J, Sneddon S, Dick IM, Dare H, Boudville N, Musk AW, Skates SJ, Robinson BW (2013) Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum. Dis Mark 35:119\u2013127. https:\/\/doi.org\/10.1155\/2013\/874212","journal-title":"Dis Mark"},{"key":"244_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3892\/mco.2013.175","volume":"1","author":"K Fukuoka","year":"2013","unstructured":"Fukuoka K, Kuribayashi K, Yamada S, Tamura K, Tabata C, Nakano T (2013) Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma. Mol Clin Oncol 1:942\u2013948. https:\/\/doi.org\/10.3892\/mco.2013.175","journal-title":"Mol Clin Oncol"},{"key":"244_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","volume":"6","author":"A Cristaudo","year":"2011","unstructured":"Cristaudo A, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Ambrosino N, Chella A, Lucchi M, Mussi A, Foddis R (2011) Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol 6:1587\u20131593. https:\/\/doi.org\/10.1097\/JTO.0b013e31821e1c08","journal-title":"J Thorac Oncol"},{"key":"244_CR13","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","volume":"6","author":"K Hollevoet","year":"2011","unstructured":"Hollevoet K, Nackaerts K, Gosselin R, De Wever W, Bosquee L, De Vuyst P, Germonpre P, Kellen E, Legrand C, Kishi Y, Delanghe JR, van Meerbeeck JP (2011) Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. J Thorac Oncol 6:1930\u20131937. https:\/\/doi.org\/10.1097\/JTO.0b013e3182272294","journal-title":"J Thorac Oncol"},{"key":"244_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/thoraxjnl-2014-205205","volume":"69","author":"J Creaney","year":"2014","unstructured":"Creaney J, Dick IM, Meniawy TM, Leong SL, Leon JS, Demelker Y, Segal A, Musk AW, Lee YC, Skates SJ, Nowak AK, Robinson BW (2014) Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma. Thorax 69:895\u2013902. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205205","journal-title":"Thorax"},{"key":"244_CR15","doi-asserted-by":"publisher","first-page":"14321","DOI":"10.1038\/s41598-018-32315-3","volume":"8","author":"G Johnen","year":"2018","unstructured":"Johnen G, Burek K, Raiko I, Wichert K, Pesch B, Weber DG, Lehnert M, Casjens S, Hagemeyer O, Taeger D, Bruning T (2018) Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin\u2014a case-control comparison nested into a prospective cohort of asbestos-exposed workers. Sci Rep 8:14321. https:\/\/doi.org\/10.1038\/s41598-018-32315-3","journal-title":"Sci Rep"},{"key":"244_CR16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.7150\/ijms.23939","volume":"15","author":"G Aguilar-Madrid","year":"2018","unstructured":"Aguilar-Madrid G, Pesch B, Calderon-Aranda ES, Burek K, Jimenez-Ramirez C, Juarez-Perez CA, Ochoa-Vazquez MD, Torre-Bouscoulet L, Acosta-Saavedra LC, Sada-Ovalle I, Garcia-Figueroa J, Alvarado-Cabrero I, Castillo-Gonzalez P, Baez-Saldana AR, Perez-Padilla JR, Osnaya-Juarez J, Rivera-Rosales RM, Garcia-Bazan EM, Bautista-Aragon YL, Lazcano-Hernandez E, Munguia-Canales DA, Argote-Greene LM, Taeger D, Weber DG, Casjens S, Raiko I, Bruning T, Johnen G (2018) Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population. Int J Med Sci 15:883\u2013891. https:\/\/doi.org\/10.7150\/ijms.23939","journal-title":"Int J Med Sci"},{"key":"244_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1471-2407-10-242","volume":"10","author":"I Raiko","year":"2010","unstructured":"Raiko I, Sander I, Weber DG, Raulf-Heimsoth M, Gillissen A, Kollmeier J, Scherpereel A, Bruning T, Johnen G (2010) Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients. BMC Cancer 10:242. https:\/\/doi.org\/10.1186\/1471-2407-10-242","journal-title":"BMC Cancer"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bbrc.2017.03.077","volume":"486","author":"I Raiko","year":"2017","unstructured":"Raiko I, Rihs HP, Gleichenhagen J, Sander I, Kollmeier J, Lehnert M, Bruning T, Johnen G (2017) A recombinant polypeptide of the megakaryocyte potentiating factor is a potential biomarker in plasma for the detection of mesothelioma. Biochem Biophys Res Commun 486:526\u2013532. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.077","journal-title":"Biochem Biophys Res Commun"},{"key":"244_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","volume":"53","author":"HL Beyer","year":"2007","unstructured":"Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, Miller MC, Verch T, Allard WJ, Pass HI, Sardesai NY (2007) MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem 53:666\u2013672. https:\/\/doi.org\/10.1373\/clinchem.2006.079327","journal-title":"Clin Chem"},{"key":"244_CR20","doi-asserted-by":"publisher","first-page":"e017104","DOI":"10.1136\/bmjopen-2017-017104","volume":"7","author":"S Casjens","year":"2017","unstructured":"Casjens S, Weber DG, Johnen G, Raiko I, Taeger D, Meinig C, Moebus S, Jockel KH, Bruning T, Pesch B (2017) Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study. BMJ Open 7:e017104. https:\/\/doi.org\/10.1136\/bmjopen-2017-017104","journal-title":"BMJ Open"},{"key":"244_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.humpath.2005.11.006","volume":"37","author":"JM Cates","year":"2006","unstructured":"Cates JM, Coffing BN, Harris BT, Black CC (2006) Calretinin expression in tumors of adipose tissue. Hum Pathol 37:312\u2013321","journal-title":"Hum Pathol"},{"key":"244_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00004347-200110000-00006","volume":"20","author":"QJ Cao","year":"2001","unstructured":"Cao QJ, Jones JG, Li M (2001) Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 20:346\u2013352","journal-title":"Int J Gynecol Pathol"},{"key":"244_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2042-6410-3-13","volume":"3","author":"K Karastergiou","year":"2012","unstructured":"Karastergiou K, Smith SR, Greenberg AS, Fried SK (2012) Sex differences in human adipose tissues\u2014the biology of pear shape. Biol Sex Differ 3:13. https:\/\/doi.org\/10.1186\/2042-6410-3-13","journal-title":"Biol Sex Differ"},{"key":"244_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/JTO.0b013e318180477b","volume":"3","author":"J Creaney","year":"2008","unstructured":"Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW (2008) Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. J Thorac Oncol 3:851\u2013857. https:\/\/doi.org\/10.1097\/JTO.0b013e318180477b","journal-title":"J Thorac Oncol"},{"key":"244_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2008.02.012","volume":"62","author":"K Iwahori","year":"2008","unstructured":"Iwahori K, Osaki T, Serada S, Fujimoto M, Suzuki H, Kishi Y, Yokoyama A, Hamada H, Fujii Y, Yamaguchi K, Hirashima T, Matsui K, Tachibana I, Nakamura Y, Kawase I, Naka T (2008) Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin. Lung Cancer 62:45\u201354. https:\/\/doi.org\/10.1016\/j.lungcan.2008.02.012","journal-title":"Lung Cancer"},{"key":"244_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","volume":"181","author":"K Hollevoet","year":"2010","unstructured":"Hollevoet K, Nackaerts K, Thimpont J, Germonpre P, Bosquee L, De Vuyst P, Legrand C, Kellen E, Kishi Y, Delanghe JR, van Meerbeeck JP (2010) Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med 181:620\u2013625. https:\/\/doi.org\/10.1164\/rccm.200907-1020OC","journal-title":"Am J Respir Crit Care Med"},{"key":"244_CR27","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1158\/1078-0432.Ccr-06-0472","volume":"12","author":"M Onda","year":"2006","unstructured":"Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I (2006) Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin Cancer Res 12:4225\u20134231. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0472","journal-title":"Clin Cancer Res"},{"key":"244_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/1078-0432.Ccr-07-1613","volume":"14","author":"K Shiomi","year":"2008","unstructured":"Shiomi K, Hagiwara Y, Sonoue K, Segawa T, Miyashita K, Maeda M, Izumi H, Masuda K, Hirabayashi M, Moroboshi T, Yoshiyama T, Ishida A, Natori Y, Inoue A, Kobayashi M, Sakao Y, Miyamoto H, Takahashi K, Hino O (2008) Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC\/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Clin Cancer Res 14:1431\u20131437. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-1613","journal-title":"Clin Cancer Res"},{"key":"244_CR29","doi-asserted-by":"publisher","first-page":"e004145","DOI":"10.1136\/bmjopen-2013-004145","volume":"4","author":"A Cui","year":"2014","unstructured":"Cui A, Jin XG, Zhai K, Tong ZH, Shi HZ (2014) Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open 4:e004145. https:\/\/doi.org\/10.1136\/bmjopen-2013-004145","journal-title":"BMJ Open"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-019-00244-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T08:37:15Z","timestamp":1610181435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-019-00244-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1007\/s00408-019-00244-1","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The IPA has received calretinin kits for a reduced price from DLD. Otherwise, none of the authors has any conflict of interest to declare in relation to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}